Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Conditions
- Advanced Glioblastoma
- Metastatic Melanoma in the Central Nervous System
- MGMT-Unmethylated Glioblastoma
Interventions
- DRUG: Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
- DRUG: Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
Sponsor
Sheba Medical Center
Collaborators